Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-019455
Filing Date
2010-03-01
Accepted
2010-03-01 17:09:37
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a55326e10vk.htm 10-K 691659
2 EX-23.1 a55326exv23w1.htm EX-23.1 1520
3 EX-31.1 a55326exv31w1.htm EX-31.1 8158
4 EX-31.2 a55326exv31w2.htm EX-31.2 8200
5 EX-32.1 a55326exv32w1.htm EX-32.1 3439
6 GRAPHIC a55326a5532601.gif GRAPHIC 12300
  Complete submission text file 0000950123-10-019455.txt   731449
Mailing Address 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO CA 92121 8585303600
ANADYS PHARMACEUTICALS INC (Filer) CIK: 0001128495 (see all company filings)

EIN.: 223193172 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50632 | Film No.: 10645661
SIC: 2834 Pharmaceutical Preparations